PGEN
Biotechnology · Healthcare
Chairman, Board Member
2025-06-26–present
Chairman
Precigen, Inc. (PGEN)Board Member
Precigen, Inc. (PGEN)Equibles does not estimate personal net worth.
Get an email with a short summary when Precigen, Inc. publishes a filing, an earnings call transcript or a press release.
Get PGEN alertsRandal Kirk is recorded as Board Member at Precigen, Inc. (PGEN) since June 26, 2025 and Chairman at Precigen, Inc. (PGEN). The newest filing on record that lists Randal Kirk as Chairman at Precigen, Inc. (PGEN) is dated April 28, 2021. The proxy statement of Precigen, Inc. reports total compensation of $2,067,617 for Randal Kirk in fiscal 2019. Disclosed compensation is on record for 3 fiscal years. Precigen, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precigen, Inc. includes Helen Sabzevari (CEO and Board Member), Helen Sabzevari, Ph.D. (CEO), Randal J. Kirk (Chairman and Board Member) and 7 others.
2025-06-26–present
Start not stated–present
Last confirmed April 28, 2021
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
PGEN
Biotechnology · Healthcare
Chairman, Board Member
2025-06-26–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Precigen, Inc. (PGEN) | Executive Chairman | — | $2,067,617 |
| 2018 | Precigen, Inc. (PGEN) | Executive Chairman | — | $2,056,450 |
| 2017 | Precigen, Inc. (PGEN) | Executive Chairman and Former Chief Executive Officer | — | $1,907,879 |
No call appearances or filed executive changes recorded yet.